BiotechTube
Home/Tubulis Technologies/Dr. Jonas Helma-Smets
DJ

Dr. Jonas Helma-Smets

Chief Scientific Officer

Tubulis Technologies

Therapeutic Areas

Oncology

Tubulis Technologies Pipeline

DrugIndicationPhase
TUB-040Solid tumors (e.g., ovarian, NSCLC) targeting NaPi2bPhase 1
TUB-030Solid tumors targeting 5T4Phase 1

Leadership Team at Tubulis Technologies

DD
Dr. Dominik Schumacher
Chief Executive Officer
DI
Dr. Ingo Lehrke
Chief Business Officer
DC
Dr. Charles Fuchs
Chief Medical Officer
View full Tubulis Technologies profile